Endothelial Cells Promote Migration of Mesenchymal Stem Cells via PDGF-BB/PDGFRβ-Src-Akt in the Context of Inflammatory Microenvironment upon Bone Defect

Table 1

Reagent information.

Reagent	Target	Concentration	Duration	Usage	Source
AMD3100	CXCR4	5 μg/ml	30 min	Pre-treat MSCs	Sigma-Aldrich, St. Louis, MO, USA
AZD0530	Src	10 μM	24 h	Pre-treat MSCs	Selleck Chemicals, Houston, TX, USA
MK-2206	Akt1/2/3	10 μM	24 h	Pre-treat MSCs	Selleck Chemicals, Houston, TX, USA
U0126	MEK1/2	50 μM	24 h	Pre-treat MSCs	Selleck Chemicals, Houston, TX, USA
SP600125	JNK1/2/3	10 μM	24 h	Pre-treat MSCs	Selleck Chemicals, Houston, TX, USA
SB203580	p38 MAPK	1 μM	30 min	Pre-treat MSCs	Selleck Chemicals, Houston, TX, USA
JNJ-10198409	PDGFRβ	5 μM	1 h	Pre-treat MSCs	MedChemExpress, Monmouth Junction, NJ, USA
SU5408	VEGFR2	5 μM	1/2d since implantation	Intraperitoneal injection	MedChemExpress, Monmouth Junction, NJ, USA